Ewing Sarcoma Family of Tumors: Resistance to Treatment and the Search for New Biomarkers

来源 :2014第七届世界癌症大会 | 被引量 : 0次 | 上传用户:caiql
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Ewing sarcoma family of tumors (ESFT) is an aggressive malignant tumor of bone and soft tissue in children and adolescents that may present with metastasis at diagnosis in 20-25% of cases.Modern treatment regimens for localized disease have resulted in significant improvement in survival.
其他文献
Cryoablation is a minimally invasive technique, highly innovative, which has only recently been usedin the treatment of primary and secondary lung tumors.Cell death is obtained as a result of rapid fr
会议
Colorectal liver metastases are common and should be considered for treatment in a multidisciplinary setting.Surgery is the treatment of choice providing the metastases are resectable.Several surgical
会议
With the advent of increased abdominal imaging, pancreatic cysts are being increasingly recognized.Most are discovered incidentally.Most cysts are benign but some which are mucinous have an increased
会议
Endometnal adenocarcinoma is the most common gynecologic malignancy and fourth most common cancer in females, ranking only behind breast, lung and colorectal cancers.Despite significant efforts to imp
会议
Pancreatic cancer is a highly aggressive malignant disease with fatal clinical outcome and high mortality.Although gemcitabine is known to be the current standard therapy for advanced pancreatic cance
会议
Breast-conserving surgery (BCS) with radiation therapy has become a standard treatment option in women with localized ductal carcinoma in situ (DCIS).Re-excision is common in BCS, partly due to lack o
会议
Patients with sub-optimal results following Breast Conservative Therapy (BCT) are presenting more frequently to plastic surgeons as a difficult management problem..Many of these patients can avoid n a
会议
Tamoxifen citrate is a selective estrogen receptor modulator that is widely used for the treatment of breast cancer.Tamoxifen inhibits estrogen-dependent tumor growth by competing with estrogen at rec
会议
Breast cancer is a heterogeneous disease that can be stratified based on the expression of molecular markers such estrogen receptor (ER), progesterone receptor and epidermal growth factor receptor 2.B
会议
Raf kinase inhibitor protein (RKIP) inhibits activation of the classical MAP kinase pathway by binding either Raf-i or MEK.Decreased RKIP has been demonstrated to be associated with the metastatic and
会议